RPG Life Sciences Limited
RPG Life Sciences Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: RPGLIFE and BSE: 532983 (ISIN INE105J01010).
It has a market capitalisation of ₹4,702 crore, a last close of ₹2,843 on 2026-10-19, a one-year return of 24.8%.
Valuation: a price-to-earnings ratio of 39.36x, a price-to-book ratio of 7.77x, a dividend yield of 0.8%.
Profitability: return on equity of 20.3%, return on capital employed of 26.5%, an operating margin of 21.1%.
Growth: sales growth of 11.3% a year over three years, net profit growth of 19.4% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.03x, promoter holding of 73.0%.
| Metric | Value |
|---|---|
| Market capitalisation | 4,702 |
| Last close | ₹2,843 |
| P/E (TTM) | 39.36x |
| P/B | 7.77x |
| Dividend yield | 0.8% |
| ROE (FY) | 20.3% |
| ROCE (FY) | 26.5% |
| Operating margin (TTM) | 21.1% |
| Sales growth, 3-year CAGR | 11.3% |
| Profit growth, 3-year CAGR | 19.4% |
| Debt / equity | 0.03x |
| Promoter holding | 73.0% |
| 1-year return | 24.8% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means